A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Conditions

Plaque Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Instituto de Neumonologia Y Dermatologia, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Contact: Study coordinator (Paula Luna) · 5491145404644
  • Psoriahue, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Contact: Study coordinator (Gabriel Magariños) · 5401148238755
  • CONEXA Investigacion Clinica S.A., Buenos Aires, Argentina

    Contact: Study coordinator (Pablo Gonzalez) · +5491154140381
  • Centro de Investigaciones Metabólicas (CINME), Buenos Aires, Argentina

    Contact: Study coordinator (Maria Laura Galimberti) · 5491154583202
  • Hospital Italiano de Buenos Aires, CABA, Argentina

    Contact: Study coordinator (Maria Angles) · +5491168360026
  • Consultora Integral de Salud, Córdoba, Argentina

    Contact: Study coordinator (Veronica Savio) · +5493515337844
  • The Skin Hospital, Darlinghurst, New South Wales, Australia

    Contact: Study coordinator (John Frew) · +409121547
  • Local Institution - 0002, Westmead, New South Wales, Australia

  • Queensland Children's Hospital, Brisbane, Queensland, Australia

    Contact: Study coordinator (Tania Zappala) · 30681111
  • Veracity Clinical Research, Woolloongabba, Queensland, Australia

    Contact: Study coordinator (Lynda Spelman) · +61730391311
  • Monash Health, Clayton, Victoria, Australia

    Contact: Study coordinator (Francis Lai) · 0395936666
  • Local Institution - 0001, Melbourne, Victoria, Australia

  • Centro de Pesquisas da Clínica IBIS, Salvador, Estado de Bahia, Brazil

    Contact: Study coordinator (Gleison Duarte) · +557199628-2914
  • Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil

    Contact: Study coordinator (André Carvalho) · +5551993785952
  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) - HCFMRP, Ribeirão Preto, São Paulo, Brazil

    Contact: Study coordinator (Cacilda da Silva Souza) · 551636022302
  • Local Institution - 0083, Rio de Janeiro, Brazil

  • Local Institution - 0067, São Paulo, Brazil

  • Local Institution - 0010, Calgary, Alberta, Canada

  • Alberta Dermasurgery Centre, Edmonton, Alberta, Canada

    Contact: Study coordinator (Jaggi Rao) · 587-487-0187
  • Local Institution - 0039, Hamilton, Ontario, Canada

  • Lynderm Research Inc., Markham, Ontario, Canada

    Contact: Study coordinator (Charles Lynde) · 9054718011
  • The Hospital for Sick Children, Toronto, Ontario, Canada

    Contact: Study coordinator (Rebecca Levy) · 4168137654x428232
  • Centre Hospitalier de Calais, Calais, France

    Contact: Study coordinator (Christopher COSSART) · 0366256173
  • Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand-dermatology, Dijon, France

    Contact: Study coordinator (Bertille Bonniaud) · 33380293336
  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, France

    Contact: Study coordinator (Thomas Hubiche) · +33492036667
  • Local Institution - 0021, Paris, France

  • Universitätsklinikum Münster, Münster, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Nina Magnolo) · 0049-251-8356558
  • Universitätsmedizin Johannes Gutenberg Universität Mainz, Mainz, Rhineland-Palatinate, Germany

    Contact: Study coordinator (Petra Staubach-Renz) · +496131175732
  • Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Saxony, Germany

    Contact: Study coordinator (Susanne Abraham) · +493514583401
  • Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin, Germany

    Contact: Study coordinator (Sonja Molin) · 030450618343
  • Kath. Kinderkrankenhaus Wilhelmstift, Hamburg, Germany

    Contact: Study coordinator (Peter Hoeger) · 00494067377202
  • Nagoya City University Hospital, Nagoya, Aichi-ken, Japan

    Contact: Study coordinator (Akimichi Morita) · +81-52-851-5511
  • Fukuoka University Hospital, Fukuoka, Jonan-Ku, Fukuoka, Japan

    Contact: Study coordinator (Shinichi Imafuku) · 81928011011
  • Local Institution - 0040, Isehara, Kanagawa, Japan

  • Mie University Hospital, Tsu, Mie-ken, Japan

    Contact: Study coordinator (Keiichi Yamanaka) · 81-59-232-1111
  • Teikyo University Hospital, Itabashi-ku, Tokyo, Japan

    Contact: Study coordinator (Yayoi Tada) · 81339641211
  • Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan

    Contact: Study coordinator (Yukari Okubo) · 81-3-3342-6111
  • Nippon Life Hospital, Osaka, Japan

    Contact: Study coordinator (Mari Higashiyama) · +81664433446
  • Crea de Guadalajara, Guadalajara, Jalisco, Mexico

    Contact: Study coordinator (Gabriel Vega Cornejo) · 3314172229
  • Grupo Clínico CATEI S.C., Guadalajara, Jalisco, Mexico

    Contact: Study coordinator (Delfina Villanueva Quintero) · 3331151992
  • RM Pharma Specialists, Mexico City, Mexico City, Mexico

    Contact: Study coordinator (Zamira Barragan-Estudillo) · 525565501629
  • Arké SMO S.A de C.V, Veracruz, Mexico

    Contact: Study coordinator (Claudia Bernabe del Rio) · +522299314102
  • Local Institution - 0011, Krakow, Poland

  • Dermoklinika Centrum Medyczne S.C. M. Kierstan, J. Narbutt, A. Lesiak, Lodz, Poland

    Contact: Study coordinator (Joanna Narbutt) · +48603756804
  • Państwowy Instytut Medyczny MSWiA-Klinika Dermatologii, Warsaw, Poland

    Contact: Study coordinator (Irena Walecka Herniczek) · 48603389394
  • WroMedica, Wroclaw, Poland

    Contact: Study coordinator (Wojciech Baran) · +48 604058690
  • Local Institution - 0080, Bucharest, Bucharest, Romania

  • Local Institution - 0081, Bucharest, Bucharest, Romania

  • Local Institution - 0088, Bucharest, Bucharest, Romania

  • CCBR Clinical Research, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Mara Mihai) · 0040743364164
  • Lotus-Med Tunari, Bucharest, Romania

    Contact: Study coordinator (Adelina-Maria Sendrea) · 0040760930352
  • Spitalul clinic de urgenta pentru copii Sf. Maria, Iași, Romania

    Contact: Study coordinator (Monica Cozorici) · 0740303215
  • Spitalul Clinic Judetean Mures, Târgu Mureş, Romania

    Contact: Study coordinator (Silviu Morariu) · +40744757246
  • Local Institution - 0048, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

  • Local Institution - 0047, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

  • The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

    JU HEE HAN · +821041383307
  • Hospital General Universitario de Alicante-Dermatology, Alicante, Spain

    Contact: Study coordinator (laura berbegal) · +34965913723
  • OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces-Dermatology, Barakaldo, Spain

    Contact: Study coordinator (Marta Mendieta Eckert) · 946006149
  • Hospital Sant Joan de Déu-URC Dermatology, Esplugues de Llobregat, Spain

    Contact: Study coordinator (Asuncion Vicente Villa) · 936009733(ext.70034)
  • Hospital Universitario de Gran Canaria Doctor Negrín-Dermatología, Las Palmas de GC, Spain

    Contact: Study coordinator (ALICIA GONZALEZ QUESADA) · +34928450659
  • Hospital Universitario 12 de Octubre-DERMATOLOGY, Madrid, Spain

    Contact: Study coordinator (Raquel Rivera-Diaz) · 34917792260
  • Hospital Universitario La Paz-UCICEC/DERMA, Madrid, Spain

    Contact: Study coordinator (Raul de Lucas Laguna) · 34917277231
  • Mounts Bay Medical, Connor Downs, United Kingdom

    Contact: Study coordinator (Richard Burkimsher) · 01736 805460
Study leads
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb